LASSBio-881

an in vivo antinociceptive & anti-inflammatory, and in vitro antiproliferative & antioxidant compound, with a cannabinoid ligand profile; structure in first source

Also Known As:

N'-(3,5-di-tert-butyl-4-hydroxybenzylidene)-6-nitro-1,3-benzodioxole-5-carbohydrazine

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Organic Chemicals: 133
- Hydrazines: 379
  - LASSBio-881: 1

Experts

1.	Barreiro, E J: 1 article (04/2010)
2.	Castro, N G: 1 article (04/2010)
3.	Duarte, C D: 1 article (04/2010)
4.	Fraga, C A M: 1 article (04/2010)
5.	Guimaraes, M Z P: 1 article (04/2010)
6.	Lima, C K F: 1 article (04/2010)
7.	Maia, R C: 1 article (04/2010)
8.	Mesquita, C M: 1 article (04/2010)
9.	Miranda, A L P: 1 article (04/2010)
10.	Santos, M L H: 1 article (04/2010)

Related Diseases

1.	Sciatic Neuropathy (Lesion of Sciatic Nerve) 04/01/2010 - "In addition, LASSBio-881 decreased the paw withdrawal responses to thermal stimuli of animals with sciatic neuropathy 7-11 days after nerve ligation, at a dose of 300 micromolkg(-1)day(-1) p.o. "
2.	Pain (Aches) 04/01/2010 - "Compound LASSBio-881 is an orally effective antinociceptive that binds to cannabinoid receptors and is active mainly on the neurogenic component of pain models. "

Related Drugs and Biologics

1.	Cannabinoid Receptors (Cannabinoid Receptor)

Related Therapies and Procedures

1.	Ligation